DIMENSIONAL FUND ADVISORS LP

Position in STTK — Shattuck Labs, Inc.

CIK 354204 AUSTIN, TX

Position in STTK

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$1,000,777

+$916,127 QoQ

Shares Held

155,642

+571.1% QoQ

Ownership

0.203%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

13 quarters on record

Voting authority Sole 77% Shared 20% None 3%

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $4,772,684,897 across 224 Biotechnology names. STTK ranks #140 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	989,342	$441,780,774
2	REGN	Regeneron Pharmaceuticals, Inc.	513,060	$396,410,676
3	JAZZ	Jazz Pharmaceuticals plc	1,895,215	$358,290,394
4	BMRN	Biomarin Pharmaceutical Inc	3,802,930	$214,827,514
5	ROIV	Roivant Sciences Ltd.	7,475,866	$207,081,486
6	INCY	Incyte Corp	1,975,544	$185,938,199
7	EXEL	Exelixis, Inc.	4,299,597	$184,409,714
8	HALO	Halozyme Therapeutics, Inc.	2,079,827	$134,419,216

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,000,777	155,642	+571.1%	Shares	Sole	2026-05-07
2025-12-31	$84,650	23,192	-63.2%	Shares	Sole	2026-02-12
2025-03-31	$59,807	62,956	0.0%	Shares	Sole	2025-05-13
2024-12-31	$76,174	62,956	-63.5%	Shares	Sole	2025-02-13
2024-09-30	$601,172	172,256	+149.4%	Shares	Sole	2024-11-07
2024-06-30	$266,578	69,062	+8.5%	Shares	Sole	2024-08-09
2024-03-31	$569,164	63,665	-13.6%	Shares	Sole	2024-05-10
2023-12-31	$525,244	73,667	-3.5%	Shares	Sole	2024-02-07
2023-09-30	$116,043	76,345	-0.5%	Shares	Sole	2023-11-09
2023-06-30	$239,352	76,716	+21.6%	Shares	Sole	2023-08-09
2023-03-31	$185,405	63,063	+14.4%	Shares	Sole	2023-05-12
2022-12-31	$128	55,133	+9.3%	Shares	Sole	2023-02-09
2022-09-30	$136,171	50,434	—	Shares	Sole	2022-11-10
No filing history on record for this holder in this stock.